Junnan Wang

1.7k total citations
83 papers, 1.3k citations indexed

About

Junnan Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Junnan Wang has authored 83 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 13 papers in Cancer Research. Recurrent topics in Junnan Wang's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (8 papers) and RNA modifications and cancer (7 papers). Junnan Wang is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (8 papers) and RNA modifications and cancer (7 papers). Junnan Wang collaborates with scholars based in China, Australia and United States. Junnan Wang's co-authors include Youyou Yan, Junduo Wu, Bin Liu, Chao Qi, Longbo Li, Hao Wu, Ye Jia, Dandan Song, Ren-qi Yao and Huan Zhang and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Junnan Wang

80 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junnan Wang China 22 543 240 163 145 120 83 1.3k
Chao Duan China 22 761 1.4× 329 1.4× 126 0.8× 184 1.3× 92 0.8× 102 1.8k
Toshihiro Takahashi Japan 23 650 1.2× 180 0.8× 257 1.6× 138 1.0× 136 1.1× 168 2.0k
Mingqi Li China 23 753 1.4× 410 1.7× 118 0.7× 120 0.8× 112 0.9× 133 2.1k
Shaokang Pan China 23 679 1.3× 328 1.4× 134 0.8× 352 2.4× 121 1.0× 66 1.4k
Guodong Chen China 24 798 1.5× 166 0.7× 80 0.5× 157 1.1× 166 1.4× 123 1.6k
Yuqi Liu China 22 841 1.5× 127 0.5× 227 1.4× 51 0.4× 189 1.6× 181 1.9k
Wenjian Wang China 29 1.3k 2.3× 383 1.6× 236 1.4× 255 1.8× 149 1.2× 132 2.7k
Bo Ning China 19 555 1.0× 122 0.5× 85 0.5× 224 1.5× 236 2.0× 109 2.0k
Shuai Ma China 24 434 0.8× 180 0.8× 63 0.4× 148 1.0× 193 1.6× 135 1.9k
Bing Yu China 18 567 1.0× 140 0.6× 59 0.4× 91 0.6× 198 1.6× 58 1.2k

Countries citing papers authored by Junnan Wang

Since Specialization
Citations

This map shows the geographic impact of Junnan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junnan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junnan Wang more than expected).

Fields of papers citing papers by Junnan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junnan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junnan Wang. The network helps show where Junnan Wang may publish in the future.

Co-authorship network of co-authors of Junnan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Junnan Wang. A scholar is included among the top collaborators of Junnan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junnan Wang. Junnan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yunfan, et al.. (2025). Inhibition of ferroptosis alleviates atherosclerosis and foam cell formation by regulating lipid metabolism via AMPK activation. International Immunopharmacology. 153. 114553–114553. 3 indexed citations
2.
4.
Wang, Junnan, Wei Xiong, Heng Zhou, et al.. (2024). The oral-brain axis: can periodontal pathogens trigger the onset and progression of Alzheimer’s disease?. Frontiers in Microbiology. 15. 1358179–1358179. 16 indexed citations
5.
Liu, Jia, Youyou Yan, Dongdong Zheng, Jifeng Zhang, & Junnan Wang. (2023). Inhibiting microRNA-200a-3p attenuates pyroptosis via targeting the SIRT1/NF-κB/NLRP3 pathway in H2O2-induced HAEC. Aging. 15(20). 11184–11200. 5 indexed citations
7.
Wang, Junnan, et al.. (2023). The Effect and Mechanism of Corilagin from Euryale Ferox Salisb Shell on LPS-Induced Inflammation in Raw264.7 Cells. Foods. 12(5). 979–979. 14 indexed citations
8.
Xu, Guang, Ziying Wei, Zhilei Wang, et al.. (2022). The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity. Cell Death Discovery. 8(1). 313–313. 12 indexed citations
9.
Li, Tianyi, Junduo Wu, Jia Liu, et al.. (2021). Protocol for the Acute Myocardial Infarction Study in Northeastern China (AMINoC): a real-world prospective cohort study. BMJ Open. 11(5). e042936–e042936. 2 indexed citations
10.
Yu, Yue, Ren-qi Yao, Yufeng Zhang, et al.. (2021). Is oxygen therapy beneficial for normoxemic patients with acute heart failure? A propensity score matched study. Military Medical Research. 8(1). 38–38. 5 indexed citations
11.
Zheng, Xianghui, Maomao Zhang, Yang Zheng, et al.. (2020). Quality indicators for cardiac rehabilitation after myocardial infarction in China: a consensus panel and practice test. BMJ Open. 10(12). e039757–e039757. 2 indexed citations
12.
Chen, Zhenzhen, Youyou Yan, Junduo Wu, et al.. (2020). Expression level and diagnostic value of exosomal NEAT1/miR‐204/MMP‐9 in acute ST‐segment elevation myocardial infarction. IUBMB Life. 72(11). 2499–2507. 46 indexed citations
13.
Yan, Youyou, Dandan Song, Junduo Wu, & Junnan Wang. (2020). Long Non-Coding RNAs Link Oxidized Low-Density Lipoprotein With the Inflammatory Response of Macrophages in Atherogenesis. Frontiers in Immunology. 11. 24–24. 31 indexed citations
14.
Yu, Yue, Peng Zhang, Ren-qi Yao, et al.. (2020). Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study. Translational Lung Cancer Research. 9(4). 1285–1301. 29 indexed citations
15.
Liu, Lulu, Bin Liu, Jiajun Ren, et al.. (2018). Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 18(1). 46–46. 18 indexed citations
16.
Tian, Dan, Ye Jia, Wenlin Huang, et al.. (2018). MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(8). 1034–1045. 30 indexed citations
17.
Wang, Zhi, Xiao Zhang, Junnan Wang, et al.. (2017). A Hybrid Learning System to Mitigate Botnet Concept Drift Attacks. 網際網路技術學刊. 18(6). 1419–1428. 2 indexed citations
18.
Wang, Junnan, et al.. (2017). Exercise and Congenital Heart Disease. Advances in experimental medicine and biology. 1000. 95–101. 7 indexed citations
19.
Yan, Youyou, et al.. (2017). The relationship of plasma decoy receptor 3 and coronary collateral circulation in patients with coronary artery disease. Life Sciences. 189. 84–88. 3 indexed citations
20.
Wang, Junnan, Youyou Yan, Dandan Song, & Bin Liu. (2016). Reduced Plasma miR-146a Is a Predictor of Poor Coronary Collateral Circulation in Patients with Coronary Artery Disease. BioMed Research International. 2016. 1–6. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026